Moderna, Inc. (MRNA) Stock price, Description, News & Info

#Thinksabio latest news

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1